Daphnetin

瑞香素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDaphnetin
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsThromboangiitis ObliteransCoronary Disease
Global Approved IndicationsThromboangiitis ObliteransCoronary Disease
Approved Indications in ChinaThromboangiitis ObliteransCoronary Disease
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsThromboangiitis ObliteransCoronary Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A